FDA APPROVES INNOVATIVE TREATMENT FOR MULTIPLE SCLEROSIS: TYSABRI (Formerly ANTEGREN)

June 28, 2006

There is new hope for the 400,000 Americans who suffer from the debilitating nervous system disease, multiple sclerosis, or MS. MS is characterized by relapses that often include symptoms such as weakness, fatigue, blurred vision, numbness and poor coordination.